Average Co-Inventor Count = 9.35
ph-index = 15
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Forma Therapeutics, Inc. (23 from 125 patents)
2. Wyeth (12 from 1,309 patents)
3. Elan Pharmaceuticals, Inc. (12 from 202 patents)
4. Other (10 from 832,843 patents)
5. Forma Tm2, Inc. (4 from 4 patents)
50 patents:
1. 12275715 - Pyridin-2(1H)-one quinolinone derivatives as mutant-isocitrate dehydrogenase inhibitors
2. 11963956 - Inhibiting mutant isocitrate dehydrogenase 1 (mIDH-1)
3. 11738018 - Inhibiting mutant isocitrate dehydrogenase 1 (mIDH-1)
4. 11576906 - Inhibiting mutant IDH-1
5. 11498913 - Pyridin-2(1H)-one quinolinone derivatives as mutant-isocitrate dehydrogenase inhibitors
6. 11497743 - Treating patients harboring an isocitrate dehydrogenase 1 (IDH-1) mutation
7. 11376246 - Inhibiting mutant IDH-1
8. 11311527 - Inhibiting mutant isocitrate dehydrogenase 1 (mIDH-1)
9. 11013733 - Inhibiting mutant isocitrate dehydrogenase 1 (mlDH-1)
10. 11013734 - Treating patients harboring an isocitrate dehydrogenase-1 (IDH-1) mutation
11. 10889567 - Pyridin-2(1H)-one quinolinone derivatives as mutant-isocitrate dehydrogenase inhibitors
12. 10807976 - Quinolinone five-membered heterocyclic compounds as mutant-isocitrate dehydrogenase inhibitors
13. 10577329 - Fused-bicyclic aryl quinolinone derivatives as mutant-isocitrate dehydrogenase inhibitors
14. 10550098 - Pyridin-2(1H)-one quinolinone derivatives as mutant-isocitrate dehydrogenase inhibitors
15. 10550099 - Quinolinone pyrimidines compositions as mutant-isocitrate dehydrogenase inhibitors